Aqua Bio Technology ASA Logo

Aqua Bio Technology ASA

ABT.OL

(0.0)
Stock Price

6,93 NOK

0% ROA

-141.43% ROE

0x PER

Market Cap.

0,00 NOK

0% DER

0% Yield

-1225.41% NPM

Aqua Bio Technology ASA Stock Analysis

Aqua Bio Technology ASA Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Aqua Bio Technology ASA Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Aqua Bio Technology ASA Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Aqua Bio Technology ASA Technical Stock Analysis
# Analysis Recommendation

Aqua Bio Technology ASA Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Aqua Bio Technology ASA Revenue
Year Revenue Growth
2008 4.783.375
2009 0 0%
2010 124.405 100%
2011 188.532 34.01%
2012 1.710.260 88.98%
2013 4.775.361 64.19%
2014 982.321 -386.13%
2015 383.882 -155.89%
2016 0 0%
2017 1.213.815 100%
2018 878.137 -38.23%
2019 891.469 1.5%
2020 444.376 -100.61%
2021 1.559.703 71.51%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Aqua Bio Technology ASA Research and Development Expenses
Year Research and Development Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Aqua Bio Technology ASA General and Administrative Expenses
Year General and Administrative Expenses Growth
2008 18.252.517
2009 5.741.090 -217.93%
2010 8.069.339 28.85%
2011 4.680.082 -72.42%
2012 6.538.046 28.42%
2013 7.370.175 11.29%
2014 10.590.412 30.41%
2015 11.396.142 7.07%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 7.255.578 100%
2021 6.232.939 -16.41%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Aqua Bio Technology ASA EBITDA
Year EBITDA Growth
2008 -4.678.503
2009 -6.329.003 26.08%
2010 -10.365.194 38.94%
2011 -8.034.021 -29.02%
2012 8.425.208 195.36%
2013 9.143.538 7.86%
2014 7.678.271 -19.08%
2015 22.583.039 66%
2016 24.369.924 7.33%
2017 -13.524.545 280.19%
2018 -17.314.735 21.89%
2019 -12.722.056 -36.1%
2020 -14.840.147 14.27%
2021 -16.567.443 10.43%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Aqua Bio Technology ASA Gross Profit
Year Gross Profit Growth
2008 87.453
2009 0 0%
2010 61.404 100%
2011 149.532 58.94%
2012 1.274.171 88.26%
2013 4.121.630 69.09%
2014 572.514 -619.92%
2015 305.882 -87.17%
2016 0 0%
2017 -139.078 100%
2018 -1.267.568 89.03%
2019 -529.588 -139.35%
2020 -537.110 1.4%
2021 607.927 188.35%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Aqua Bio Technology ASA Net Profit
Year Net Profit Growth
2008 -36.088.681
2009 -8.579.104 -320.66%
2010 -14.923.095 42.51%
2011 -13.472.249 -10.77%
2012 897.584 1600.95%
2013 2.820.627 68.18%
2014 916.808 -207.66%
2015 17.449.080 94.75%
2016 15.199.700 -14.8%
2017 -16.058.852 194.65%
2018 -18.360.128 12.53%
2019 -13.215.518 -38.93%
2020 -14.952.944 11.62%
2021 -19.112.764 21.76%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Aqua Bio Technology ASA Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2008 -37
2009 -3 -1133.33%
2010 -3 0%
2011 -3 -50%
2012 0 0%
2013 0 0%
2014 0 0%
2015 3 100%
2016 0 0%
2017 -2 100%
2018 -3 0%
2019 -1 -100%
2020 -1 0%
2021 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Aqua Bio Technology ASA Free Cashflow
Year Free Cashflow Growth
2008 -14.909.359
2009 -8.425.930 -76.95%
2010 -9.387.526 10.24%
2011 -8.507.339 -10.35%
2012 2.662.865 419.48%
2013 5.374.601 50.45%
2014 5.241.258 -2.54%
2015 19.896.966 73.66%
2016 12.242.524 -62.52%
2017 -17.297.513 170.78%
2018 -17.671.281 2.12%
2019 -17.212.334 -2.67%
2020 -13.470.695 -27.78%
2021 -24.836.996 45.76%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Aqua Bio Technology ASA Operating Cashflow
Year Operating Cashflow Growth
2008 -12.865.538
2009 -8.066.996 -59.48%
2010 -9.094.013 11.29%
2011 -7.470.343 -21.73%
2012 5.739.879 230.15%
2013 6.113.854 6.12%
2014 7.453.089 17.97%
2015 21.879.340 65.94%
2016 12.650.783 -72.95%
2017 -16.362.012 177.32%
2018 -17.312.846 5.49%
2019 -17.194.496 -0.69%
2020 -13.335.007 -28.94%
2021 -20.969.382 36.41%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Aqua Bio Technology ASA Capital Expenditure
Year Capital Expenditure Growth
2008 2.043.821
2009 358.934 -469.41%
2010 293.513 -22.29%
2011 1.036.996 71.7%
2012 3.077.014 66.3%
2013 739.253 -316.23%
2014 2.211.831 66.58%
2015 1.982.374 -11.57%
2016 408.259 -385.57%
2017 935.501 56.36%
2018 358.435 -161%
2019 17.838 -1909.39%
2020 135.688 86.85%
2021 3.867.614 96.49%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Aqua Bio Technology ASA Equity
Year Equity Growth
2008 61.391.299
2009 61.741.664 0.57%
2010 58.726.289 -5.13%
2011 51.074.170 -14.98%
2012 61.991.921 17.61%
2013 65.930.391 5.97%
2014 66.316.759 0.58%
2015 76.728.086 13.57%
2016 61.772.209 -24.21%
2017 38.528.911 -60.33%
2018 19.908.783 -93.53%
2019 7.322.956 -171.87%
2020 8.321.078 12%
2021 18.706.420 55.52%
2022 7.597.241 -146.23%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Aqua Bio Technology ASA Assets
Year Assets Growth
2008 75.453.563
2009 71.834.501 -5.04%
2010 69.093.323 -3.97%
2011 67.531.181 -2.31%
2012 78.165.579 13.6%
2013 78.269.026 0.13%
2014 75.759.177 -3.31%
2015 86.069.549 11.98%
2016 71.422.570 -20.51%
2017 49.089.054 -45.5%
2018 30.041.224 -63.41%
2019 10.386.123 -189.24%
2020 16.237.927 36.04%
2021 34.429.500 52.84%
2022 21.087.641 -63.27%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Aqua Bio Technology ASA Liabilities
Year Liabilities Growth
2008 14.062.264
2009 10.092.837 -39.33%
2010 10.367.034 2.64%
2011 16.457.011 37.01%
2012 16.173.658 -1.75%
2013 12.338.635 -31.08%
2014 9.442.418 -30.67%
2015 9.341.463 -1.08%
2016 9.650.361 3.2%
2017 10.560.143 8.62%
2018 10.132.441 -4.22%
2019 3.063.167 -230.78%
2020 7.916.849 61.31%
2021 15.723.080 49.65%
2022 13.490.400 -16.55%

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Aqua Bio Technology ASA Dividends
Year Dividends Growth
2015 1
2016 2 100%
2017 1 0%

Aqua Bio Technology ASA Profile

About Aqua Bio Technology ASA

Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is based in Lysaker, Norway.

CEO
Mr. Havard Lindstrom
Employee
5
Address
Fornebuveien 37
Lysaker, 1366

Aqua Bio Technology ASA Executives & BODs

Aqua Bio Technology ASA Executives & BODs
# Name Age
1 Mr. Espen Østhagen Kvale
Chief Operating Officer
70
2 Mr. Håvard Lindstrøm
Chief Executive Officer
70
3 Mr. Hans Kristian Leren
Chief Technology Officer
70
4 Mr. Havard Lindstrom
Chief Executive Officer
70

Aqua Bio Technology ASA Competitors